Transient abnormal myelopoiesis associated with down syndrome presenting as severe hydrops fetalis: A case report

Fetal Diagnosis and Therapy

Volumn 27, Issue 3, 2010, Pages 171-173

  Malin, G L ^a   Kilby, M D ^a,b   Velangi, M ^c  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

Down syndrome; Fetal hydrops; Hydrops fetalis; Myelopoiesis; Non immune; Transient abnormal

Indexed keywords

DNA; GAMMA GLUTAMYLTRANSFERASE; TRANSCRIPTION FACTOR GATA 1;

ADULT; ANEMIA; ARTICLE; ASCITES; AUTOPSY; BLOOD SMEAR; CASE REPORT; CESAREAN SECTION; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DOPPLER FLOWMETRY; DOWN SYNDROME; FEMALE; FETUS; FETUS BLOOD SAMPLING; FETUS DISEASE; FETUS ECHOGRAPHY; FETUS HYDROPS; FETUS KARYOTYPING; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE DELETION; GENETIC COUNSELING; HEART VENTRICLE SEPTUM DEFECT; HUMAN; IMMUNOPHENOTYPING; INTRAUTERINE BLOOD TRANSFUSION; LEUKEMIA; MIDDLE CEREBRAL ARTERY; MUTATIONAL ANALYSIS; MYELOPOIESIS; NEWBORN; NEWBORN DEATH; PARENT COUNSELING; PERICARDIAL EFFUSION; PRIORITY JOURNAL; TRANSIENT ABNORMAL MYELOPOIESIS; TRISOMY 12; UMBILICAL ARTERY;

ADULT; DOWN SYNDROME; FATAL OUTCOME; FEMALE; HUMANS; HYDROPS FETALIS; INFANT, NEWBORN; MYELOPOIESIS; PREGNANCY; PREGNANCY TRIMESTER, THIRD;

EID: 77951880953     PISSN: 10153837     EISSN: None     Source Type: Journal    
DOI: 10.1159/000284928     Document Type: Article

References (11)

1. Bellini C, Henneham RCM, Bonioli E: Etiology of nonimmune hydrops fetalis: a systematic review. Am J Med Gen A 2009; 149A:844-851.
2. McCoy MC, Katz VL, Gould N, Kuller JA: Non-immune hydrops after 20 weeks gestation: review of 10 years experience with suggestions for management. Obstet Gynecol 1995; 85: 578-582.
3. Sohan K, Carroll SG, De La FS, Soothill P, Kyle P: Analysis of outcome in hydrops fetalis in relation to gestational age at diagnosis, cause and treatment. Acta Obstet Gynecol Scand 2001; 80: 726-730. (Pubitemid 32802549)
4. Young NS: Parvovirus B19. N Engl J Med 2004; 350: 586-597.
5. Hendricks S, Sorensen TK, Baker ER: Trisomy 21, fetal hydrops and anaemia: prenatal diagnosis of transient myeloproliferative disorder? Obstet Gynecol 1993; 84: 703-705. (Pubitemid 23276511)
6. Pine SR, Guo Q, Yin C, Jayabose S, Druschel CM, Sandoval C: Incidence and clinical implications of GATA1 mutations in newborns with Down syndrome. Blood 2007; 110: 2128-2131. (Pubitemid 47443931)
7. Kim GJ, Lee ES: Prenatal diagnosis of transient abnormal myelopoiesis in a Down syndrome fetus. Korean J Radiol 2009; 10: 190-193.
8. Vyas P, Roberts I: Down myeloid disorders: a paradigm for childhood preleukaemia and leukaemia and insights into normal megakaryopoiesis. Early Hum Dev 2006; 82: 767-773. (Pubitemid 44692412)
9. Webb D, Roberts I, Vyas P: Haematology of Down syndrome. Arch Dis Child Fetal Neonatal Ed 2007; 92:F503-F507.
10. Hamada H, Yamada N, Watanabe H, Okuno S, Fujiki Y, Kubo T: Hypoechoic hepatomegaly associated with transient abnormal myelopoiesis provides clues to trisomy 21 in the third-trimester fetus. Ultrasound Obstet Gynecol 2001; 17: 442-444.
11. Bellini C, Hennekam RCM, Bonioli E: A diagnostic flow chart for non-immune hydrops fetalis. Am J Med Gen A 2009; 149A:852-853.